Print Print page | E-mail E-mail page

Media

Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.

  Click here to download our most recent fact sheet.

= Add Release to Briefcase
All Releases
View Summary Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
Jan 9, 2009
PDF 9.2 KB Add to Briefcase
View Summary Anesiva Announces Changes to Its Board of Directors and Receives Notification From Nasdaq
Dec 19, 2008
PDF 10.1 KB Add to Briefcase
View Summary Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
Dec 16, 2008
PDF 12.2 KB Add to Briefcase
View Summary Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
Nov 10, 2008
PDF 13.4 KB Add to Briefcase
View Summary Anesiva Secures Financing for Up to $30 Million
Oct 2, 2008
PDF 13.5 KB Add to Briefcase
Showing 1-5 of 203 releases Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41  See Next 5

MEDIA CONTACTS

Carol DeGuzman
Senior Director, Investor Relations
650-624-9600
[email protected]